The dark sides of amyloid in Alzheimer's disease pathogenesis

FEBS Letters

Volumn 588, Issue 5, 2014, Pages 641-652

  Sorrentino, Pierpaolo ^a   Iuliano, Antonietta ^b,c   Polverino, Arianna ^b,c   Jacini, Francesca ^b,c   Sorrentino, Giuseppe ^b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c Istituto di Diagnosi e Cura Hermitage Capodimonte   (Italy)

Author keywords

Alzheimer's disease; Amyloid; Cell cycle regulation; Endo lysosomal trafficking; Neuronal survival; Presenilin; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; MAMMALIAN TARGET OF RAPAMYCIN; PRESENILIN;

ALZHEIMER DISEASE; APP GENE; BRAIN REGION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOCYTOSIS; GENE; HIPPOCAMPAL CA1 REGION; HUMAN; LYSOSOME; NERVE CELL PLASTICITY; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR;

ALZHEIMER'S DISEASE; AMYLOID; CELL CYCLE REGULATION; ENDO-LYSOSOMAL TRAFFICKING; NEURONAL SURVIVAL; PRESENILIN; SYNAPTIC PLASTICITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; AMYLOID; ANIMALS; CELL SURVIVAL; HUMANS; NEURONAL PLASTICITY; NEURONS; PRESENILINS; PROTEIN TRANSPORT; RISK FACTORS; SYNAPSES;

EID: 84896695262     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.12.038     Document Type: Review

References (169)

1. P.G. Ridge, M.T. Ebbert, and J.S. Kauwe Genetics of Alzheimer's disease Biomed. Res. Int. 2013 2013 254954 10.1155/2013/254954
2. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 8000 1976 1403
3. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184
4. G. Zubenko Molecular neurobiology of Alzheimer's disease (Syndrome?) Harv. Rev. Psychiatry 5 4 1997 177 213
5. Z.S. Khachaturian Diagnosis of Alzheimer's disease Arch. Neurol. 42 1985 1097 1105
6. A. Weidemann, G. Konig, D. Bunke, P. Fischer, J.M. Salbaum, C.L. Masters, and K. Beyreuther Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein Cell 57 1 1989 115 126
7. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, and M. Citron Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735
8. I. Hussain, D. Powell, D.R. Howlett, D.G. Tew, T.D. Meek, C. Chapman, I.S. Gloger, K.E. Murphy, C.D. Southan, D.M. Ryan, T.S. Smith, D.L. Simmons, F.S. Walsh, C. Dingwall, and G. Christie Identification of a novel aspartic protease (Asp 2) as beta-secretase Mol. Cell. Neurosci. 14 1999 419
9. R. Fluhrer, A. Capell, G. Westmeyer, M. Willem, B. Hartung, M.M. Condron, D.B. Teplow, C. Haas, and J. Walter A non-amyloidogenic function of BACE-2 in the secretory pathway J. Neurochem. 81 2002 1011
10. E. Tischer, and B. Cordell Beta-amyloid precursor protein. Location of transmembrane domain and specificity of gamma-secretase cleavage J. Biol. Chem. 271 1996 21914
11. H. Steiner, K. Duff, A. Capell, H. Romig, M.G. Grim, S. Lincoln, J. Hardy, X. Yu, M. Picciano, K. Fechteler, M. Citron, R. Kopan, B. Pesold, S. Keck, M. Baader, T. Tomita, T. Iwatsubo, R. Baumeister, and C. Haas A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling J. Biol. Chem. 274 1999 28669
12. W.P. Esler, W.T. Kimberly, B.L. Ostaszewski, T.S. Diehl, C.L. Moore, J.Y. Tsai, T. Rahmati, W. Xia, D.J. Selkoe, and M.S. Wolfe Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1 Nat. Cell Biol. 2 2000 428
13. M. Shoji, T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.D. Cai, D.M. McKay, R. Tintner, and B. Frangione Production of the Alzheimer amyloid beta protein by normal proteolytic processing Science 258 1992 126
14. C. Haass, A.Y. Hung, M.G. Schlossmacher, D.B. Teplow, and D.J. Selkoe Beta-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms J. Biol. Chem. 268 1993 3021 3024
15. S.W. Pimplikar, and K. Ghosal Amyloid precursor protein: more than just neurodegeneration Stem Cell Res. Ther. 2 5 2011 39 10.1186/scrt80
16. M.S. Shearman, C.I. Ragan, and L.L. Iversen Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death Proc. Natl. Acad. Sci. USA 91 4 1994 1470 1474
17. C. Behl, J.B. Davis, R. Lesley, and D. Schubert Hydrogen peroxide mediates beta protein toxicity Cell 77 6 1994 817 827
18. M.P. Mattson, K.J. Tomaselli, and R.E. Rydel Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF Brain Res. 621 1 1993 35 49
19. C.J. Pike, D. Burdick, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state J. Neurosci. 13 4 1993 1676 1687
20. D.M. Araujo, and C.W. Cotman Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease Brain Res. 569 1 1992 141 145
21. M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R.E. Rydel Beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to exitotoxicity J. Neurosci. 12 2 1992 376 389
22. A. Copani, J.Y. Koh, and C.W. Cotman Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation Neuroreport 2 12 1991 763 765
23. J.N. Kanfer, G. Sorrentino, and D.S. Sitar Phospholipases as mediators of amyloid beta peptide neurotoxicity: an early event contributing to neurodegeneration characteristic of Alzheimer's disease Neurosci. Lett. 257 2 1998 93 96
24. S. Kar, D. Seto, P. Gaudreau, and R. Quirion Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices J. Neurosci. 16 3 1996 1034 1040
25. E. Vaucher, N. Aumont, D. Pearson, W. Rowe, J. Poirer, and S. Kar Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats J. Chem. Neuroanat. 21 4 2001 323 329
26. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 1993 921 923
27. K. Alagiakrishnan, S.S. Gill, and A. Fagarasanu Genetics and epigenetics of Alzheimer's disease Postgrad. Med. J. 88 2012 522 529 10.1136/postgradmedj- 2011-130363
28. S.W. Pimplikar, R.A. Nixon, N.K. Robakis, J. Shen, and L.-H. Tsai Amyloid-independent mechanisms in Alzheimer's disease pathogenesis J. Neurosci. 30 45 2010 14946 14954 10.1523/JNEUROSCI.4305-10.2010
29. L. Davies, B. Wolska, C. Hilbich, G. Multhaup, R. Martins, G. Simms, K. Beyreuther, and C.L. Masters A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques Neurology 38 11 1988 1688 1693
30. D.M. Mann, D. Jones, P.W. South, J.S. Snowden, and D. Neary Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease Acta Neuropathol. 83 4 1992 415 419
31. E.D. Hall, J.A. Oostveen, E. Dunn, and D.B. Carter Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils Exp. Neurol. 135 1 1995 17 27 10.1006/exnr.1995.1062
32. K. Jendroska, W. Poewe, S.E. Daniel, J. Pluess, H. Iwerssen-Schmidt, J. Paulsen, S. Barthel, L. Schelosky, J. Cervos-Navarro, and S.J. DeArmond Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain Acta Neuropathol. 90 5 1995 461 466
33. J. Joseph, B. Shukitt-Hale, N.A. Denisova, A. Martin, G. Perry, and M.A. Smith Copernicus revisited: amyloid beta in Alzheimer's disease Neurobiol. Aging 22 1 2001 131 146
34. N. Murakami, T. Yamaki, Y. Iwamoto, T. Sakakibara, N. Kobori, S. Fushiki, and S. Ueda Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus J. Neurotrauma. 15 11 1998 993 1003
35. J. Shi, Y. Xiang, and J.W. Simpkins Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells Brain Res. 772 1-2 1997 247 251
36. J. Shi, S.H. Yang, L. Stubley, A.L. Day, and J.W. Simpkins Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model Brain Res. 853 1 2000 1 4
37. M. Yokota, T.C. Saido, E. Tani, I. Yamaura, and N. Minami Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia J. Cereb. Blood Flow Metab. 16 6 1996 1219 1223 10.1097/00004647-199611000-00016
38. F. Coria, E.M. Castano, and B. Frangione Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein Am. J. Pathol. 129 1987 422 428
39. E. Lewy, M.D. Carman, I.J. Fernandez-Madrid, M.D. Power, I. Lieberburg, S.G. van Duinen, G.T. Bots, W. Luyendijk, and B. Frangione Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type Science 248 1990 1124 1126
40. C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins, A. Bayer, R.W. Jones, R. Bullock, S. Love, J.W. Neal, E. Zotova, and J.A.R. Nicoll Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial Lancet 372 2008 216 223 10.1016/S0140-6736(08)61075-2
41. S. Salloway, R. Sperling, S. Gilman, N.C. Fox, K. Blennow, M. Raskind, M. Sabbagh, L.S. Honig, R. Dood, C.H. van Dyck, R. Mulnard, J. Barakos, K.M. Gregg, E. Liu, I. Lieberburg, D. Schenk, R. Black, and M. Grundman A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease Neurology 73 2009 2061 2070 10.1212/WNL.0b013e3181c67808
42. M. Farlow, S.E. Arnold, C.H. van Dyck, P.S. Aisen, B.J. Snider, A.P. Porsteinsson, S. Friedrich, R.A. Dean, C. Gonzales, G. Sethuraman, R.B. DeMattos, R. Mohs, S.M. Paul, and E.R. Siemers Safety and biomarker effects of solanezumab in patients with Alzheimer's disease Alzheimer's Dementia 8 4 2012 261 271 10.1016/j.jalz.2011.09.224
43. M. Lehmann, P.M. Ghosh, C. Madison, R. Laforce Jr., C. Corbetta-Rastelli, M.W. Weiner, M.D. Greicius, W.W. Seeley, M.L. Gorno-Tempini, H.L. Rosen, B.L. Miller, W.J. Jaqust, and G.D. Rabinovici Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease Brain 136 Pt 3 2013 844 858 10.1093/brain/aws327
44. J. Apelt, A. Kumar, and R. Schliebs Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein Brain Res. 953 1-2 2002 17 30
45. K.R. Bales, E.T. Tzavara, S. Wu, M.R. Wade, F.P. Bymaster, S.M. Paul, and G.G. Nomikos Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody J. Clin. Invest. 116 3 2006 825 832
46. M. Pákáski, and J. Kálmán Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease Neurochem. Int. 53 5 2008 103 111 10.1016/j.neuint.2008.06.005
47. C.A. Davies, D.M. Mann, P.Q. Sumpter, and P.O. Yates A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease J. Neurol. Sci. 78 1987 151 164
48. R.L. Neve, and N.K. Robakis Alzheimer's disease: a re-examination of the amyloid hypothesis Trends Neurosci. 21 1 1998 15 19
49. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price, and L.J. Martin Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease J. Neuropathol. Exp. Neurol. l56 1997 933 944
50. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058
51. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, and L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc. Natl. Acad. Sci. USA 96 6 1999 3228 3233
52. D. Zhang, C. Zhang, A. Ho, A. Kirkwood, T.C. Sudhof, and J. Shen Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction J. Neurochem. 115 5 2010 1215 1221 10.1111/j.1471-4159.2010.07011.x
53. C.A. Saura, G. Chen, S. Malkani, S.Y. Choi, R.H. Takahashi, D. Zhang, G.K. Gouras, A. Kirkwood, R.G. Morris, and J. Shen Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice J. Neurosci. 25 29 2005 6755 6764 10.1523/JNEUROSCI.1247-05.2005
54. C. Zhang, B. Wu, V. Beglopoulos, M. Wines-Samuelson, D. Zhang, I. Dragatsis, T.C. Sudhof, and J. Shen Presenilins are essential for regulating neurotransmitter release Nature 460 2009 632 636 10.1038/nature08177
55. K.G. Pratt, P. Zhu, H. Watari, D.G. Cook, and J.M. Sullivan A novel role for {gamma}-secretase: selective regulation of spontaneous neurotransmitter release from hippocampal neurons J. Neurosci. 31 3 2011 899 906 10.1523/JNEUROSCI.4625-10.2011
56. C.A. Saura, S.Y. Choi, V. Beglopoulos, S. Malkani, D. Zhang, B.S. Shankaranarayana Rao, S. Chattarji, R.J. Kelleher 3rd, E.R. Kandel, K. Duff, A. Kirkwood, and J. Shen Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration Neuron 42 1 2004 23 36
57. H. Watanabe, M.J. Smith, E. Heilig, V. Beglopoulos, R.J. Kelleher 3rd, and J. Shen Indirect regulation of presenilins in CREB-mediated transcription J. Biol. Chem. 284 2009 13705 13713 10.1074/jbc.M809168200
58. V. Beglopoulos, X. Sun, C.A. Saura, C.A. Lemere, R.D. Kim, and J. Shen Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice J. Biol. Chem. 279 45 2004 46907 46914 10.1074/jbc.M409544200
59. M. Wines-Samuelson, E.C. Schulte, M.J. Smith, C. Aoki, X. Liu, R.J. Kelleher 3rd, and J. Shen Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice PLoS One 5 4 2010 e10195 10.1371/journal.pone.0010195
60. Y. Wang, N.H. Greig, Q.S. Yu, and M.P. Mattson Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices Neurobiol. Aging 30 7 2009 1061 1068
61. Y. Yang, and D.G. Cook Presenilin-1 deficiency impairs glutamate-evoked intracellular calcium responses in neurons Neuroscience 124 3 2004 501 505
62. B. Laursen, A. Mørk, N. Plath, U. Kristiansen, and J. Frank Bastlund Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration Brain Res. 2013 10.1016/j.brainres.2013.10.055
63. B. De Strooper, W. Annaert, P. Cupers, P. Saftig, K. Craessaerts, J.S. Mumm, E.H. Schroeter, V. Schrijvers, M.S. Wolfe, W.J. Ray, A. Goate, and R. Kopan A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain Nature 398 1999 518 522 10.1038/19083
64. J.L. Ables, J.J. Breunig, A.J. Eisch, and P. Rakic Not(ch) just development: Notch signalling in the adult brain Nat. Rev. Neurosci. 12 5 2011 269 283 10.1038/nrn3024
65. S.A. Bonini, G. Ferrari-Toninelli, G. Maccarinelli, P. Bettinsoli, M. Montinaro, and M. Memo Cytoskeletal protection: acting on Notch to prevent neuronal dysfunction Neurodegener. Dis. 2013 10.1159/000354230
66. S.W. Barger, and M.P. Mattson Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor Brain. Res. Mol. Brain Res. 40 1 1996 116 126
67. M.P. Mattson, Z.H. Guo, and J.D. Geiger Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism J. Neurochem. 73 2 1999 532 537
68. K. Furukawa, S.W. Barger, E.M. Blalock, and M.P. Mattson Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid- precursor protein Nature 379 6560 1996 74 78
69. R.J. Griffin, A. Moloney, M. Kelliher, J.A. Johnston, R. Ravid, P. Dockery, R. O'Connor, and C. O'Neill Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology J. Neurochem. 93 1 2005 105 117
70. A.M. Moloney, R.J. Griffin, S. Timmons, R. O'Connor, R. Ravid, and C. O'Neill Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signaling Neurobiol. Aging 31 2010 224 243 10.1016/j.neurobiolaging.2008.04.002
71. J.J. Pei, and J. Hugon MTOR-dependent signalling in Alzheimer's disease J. Cell. Mol. Med. 12 2008 2525 2532 10.1111/j.1582-4934.2008.00509.x
72. K. Talbot, H.Y. Wang, H. Kazi, L.Y. Han, K.P. Bakshi, A. Stucky, R.L. Fuino, K.R. Kawaguchi, A.J. Samoyedny, R.S. Wilson, Z. Arvanitakis, J.A. Schneider, B.A. Wolf, D.A. Bennett, J.Q. Trojanowski, and S.E. Arnold Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J. Clin. Invest. 122 2012 1316 1338 10.1172/JCI59903
73. X. Li et al. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain FEBS J. 272 2005 4211 4220
74. T. Ma, C.A. Hoeffer, E. Capetillo-Zarate, F. Yu, H. Wong, M.T. Lin, D. Tampellini, E. Klann, R.D. Blitzer, and G.K. Gouras Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease PLoS One 5 9 2010 10.1371/journal.pone.0012845
75. A.D. Alonso, I. Grundke-Iqbal, H.S. Barra, and K. Iqbal Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau Proc. Natl. Acad. Sci. USA 94 1997 298 303
76. C.X. Gong, F. Liu, I. Grundke-Iqbal, and K. Iqbal Post-translational modifications of tau protein in Alzheimer's disease J. Neural. Transm. 112 2005 813 838
77. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration Eur. J. Neurosci. 25 1 2007 59 68
78. E. Kickstein, S. Krauss, P. Thornhill, D. Rutschow, R. Zeller, J. Sharkey, R. Williamson, M. Fuchs, A. Köhler, H. Glossmann, R. Schneider, C. Sutherland, and S. Schweiger Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signalling PNAS 107 50 2010 21830 21835 10.1073/pnas.0912793107
79. Y. Goldberg Protein phosphatase 2A: Who shall regulate the regulator? Biochem. Pharmacol. 57 1999 321 328
80. L.M. Ittner, and J. Gotz Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease Nat. Rev. Neurosci. 12 2011 65 72 10.1038/nrn2967
81. M. Morris, S. Maeda, K. Vossel, and L. Mucke The many faces of tau Neuron 70 2011 410 426 10.1016/j.neuron.2011.04.009
82. A. Caccamo, S. Majumder, A. Richardson, R. Strong, and S. Oddo Molecular interplay between mammalian target of rapamycin (mTOR), amyloidbeta, and tau: effects on cognitive impairments J. Biol. Chem. 285 2010 13107 13120 10.1074/jbc.M110.100420
83. A. Caccamo, M.A. Maldonado, S. Majumder, D.X. Medina, W. Holbein, A. Magri, and S. Oddo Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism J. Biol. Chem. 286 2011 8924 8932 10.1074/jbc.M110.180638
84. S. Majumder et al. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling Aging Cell 11 2012 326 335 10.1111/j.1474-9726.2011.00791.x
85. M. Nizzari, V. Venezia, E. Repetto, V. Caorsi, R. Magrassi, M.C. Gagliani, P. Carlo, T. Florio, G. Schettini, C. Tacchetti, T. Russo, A. Diaspro, and C. Russo Amyloid precursor protein and presenilin1 interact with the adaptor GRB2 and modulate ERK1,2 signaling J. Biol. Chem. 282 18 2007 13833 13844
86. P. Chapouton, P. Skupien, B. Hesl, M. Coolen, J.C. Moore, R. Madelaine, E. Kremmer, T. Faus-Kessler, P. Blader, N.D. Lawson, and L. Bally-Cuif Notch activity levels control the balance between quiescence and recruitment of adult neural stem cells J. Neurosci. 30 2010 7961 7974 10.1523/JNEUROSCI.6170-09.2010
87. J.L. Ables, N.A. Decarolis, M.A. Johnson, P.D. Rivera, Z. Gao, D.C. Cooper, F. Radtke, J. Hsieh, and A.J. Eisch Notch1 is required for maintenance of the reservoir of adult hippocampal stem cells J. Neurosci. 30 2010 10484 10492 10.1523/JNEUROSCI.4721-09.2010
88. I. Imayoshi, M. Sakamoto, M. Yamaguchi, K. Mori, and R. Kageyama Essential roles of Notch signalling in maintenance of neural stem cells in developing and adult brains J. Neurosci. 30 2010 3489 3498 10.1523/JNEUROSCI. 4987-09.2010
89. S. Doxsey, W. Zimmerman, and K. Mikule Centrosome control of the cell cycle Trends Cell Biol. 15 2005 303 311
90. O. Berezovska, P. Ramdya, J. Skoch, M.S. Wolfe, B.J. Bacskai, and B.T. Hyman Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging J. Neurosci. 23 2003 4560 4566
91. G. Ferrari-Toninelli, S.A. Bonini, P. Bettinsoli, D. Uberti, and M. Memo Microtubule stabilizing effect of notch activation in primary cortical neurons Neuroscience 154 2008 946 952 10.1016/j.neuroscience.2008.04.025
92. I. Caille, B. Allinquant, E. Dupont, C. Bouillot, A. Langer, U. Muller, and A. Prochiantz Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone Development 131 2004 2173 2181
93. N. Gakhar-Koppole, P. Hundeshagen, C. Mandl, S.W. Weyer, B. Allinquant, U. Muller, and F. Ciccolini Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway Eur. J. Neurosci. 28 2008 871 882 10.1111/j.1460-9568.2008.06398.x
94. H. Zheng, M. Jiang, M.E. Trumbauer, D.J. Sirinathsinghji, R. Hopkins, D.W. Smith, R.P. Heavens, G.R. Dawson, S. Boyce, M.W. Conner, K.A. Stevens, H.H. Slunt, S.S. Sisoda, H.Y. Chen, and L.H. Van der Ploeg Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity Cell 81 1995 525 531
95. S. Ring, S.W. Weyer, S.B. Kilian, E. Waldron, C.U. Pietrzik, M.A. Filippov, J. Herms, C. Buchholz, C.B. Eckman, M. Korte, D.P. Wolfer, and U.C. Müller The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice J. Neurosci. 27 2007 7817 7826
96. S. Chasseigneaux, L. Dinc, C. Rose, C. Chabret, F. Coulpier, P. Topilko, G. Mauger, and B. Allinquant Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway PLoS One 6 2011 e16301 10.1371/journal.pone. 0016301
97. X. Cao, and T.C. Sudhof A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60 Science 293 5527 2001 115 120 10.1126/science.1058783
98. Y. Gao, and S.W. Pimplikar The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus Proc. Natl. Acad. Sci. USA 98 26 2001 14979 14984 10.1073/pnas.261463298
99. K.A. Ryan, and S.W. Pimplikar Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain J. Cell Biol. 171 2 2005 327 335 10.1083/jcb.200505078
100. K. Ghosal, A. Stathopoulos, and S.W. Pimplikar APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation PLoS One 5 7 2010 e11866 10.1371/journal.pone.0011866
101. K. Ghosal, D.L. Vogt, M. Liang, Y. Shen, and B.T. Lamb et al. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain Proc. Natl. Acad. Sci. USA 106 2009 18367 18372 10.1073/pnas.0907652106
102. D.L. Vogt, D. Thomas, V. Galvan, D.E. Bredesen, B.T. Lamb, and S.W. Pimplikar Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain Neurobiol. Aging 32 9 2009 1725 1729 10.1016/j.neurobiolaging.2009.09.002
103. M. Goedert Oskar Fischer and the study of dementia Brain 132 2009 1102 1111 10.1093/Brain/Awn256
104. R.A. Nixon, J. Wegiel, A. Kumar, W.H. Yu, C. Peterhoff, A. Cataldo, and A.M. Cuervo Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study J. Neuropathol. Exp. Neurol. 64 2 2005 113 122
105. W.C. Benzing, E.J. Mufson, and D.M. Armstrong Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present Brain Res. 606 1 1993 10 18
106. R.A. Nixon, and A.M. Cataldo Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease J. Alzheimer's Dis. 9 3 Suppl. 2006 277 289
107. R.A. Nixon, D.S. Yang, and J.H. Lee Neurodegenerative lysosomal disorders: a continuum from development to late age Autophagy 4 5 2008 590 599
108. C.M. Bellettato, and M. Scarpa Pathophysiology of neuropathic lysosomal storage disorders J. Inherit. Metab. Dis. 33 4 2010 347 362 10.1007/S10545-010- 9075-9
109. J.H. Lee, W.H. Yu, A. Kumar, S. Lee, P.S. Mohan, C.M. Peterhoff, D.M. Wolfe, M. Martinez-Vicente, A.C. Massey, G. Sovak, Y. Uchiyama, D. Westaway, A.M. Cuervo, and R.A. Nixon Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations Cell 141 7 2010 1146 1158 10.1016/j.cell.2010.05.008
110. K. Ohmi, L.C. Kudo, S. Ryazantsev, H.Z. Zhao, S.L. Karsten, and E.F. Neufeld Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy Proc. Natl. Acad. Sci. USA 106 20 2009 8332 8337 10.1073/pnas. 0903223106
111. M. Sardiello, M. Palmieri, A. di Ronza, D.L. Medina, M. Valenza, V.A. Gennarino, C. Di Malta, F. Donaudy, V. Embrione, R.S. Polishchuk, S. Banfi, G. Parenti, E. Cattaneo, and A. Ballabio A gene network regulating lysosomal biogenesis and function Science 325 2009 473 477 10.1126/science.1174447
112. R. Dobrowolski, P. Vick, D. Ploper, I. Gumper, H. Snitkin, D.D. Sabatini, and E.M. De Robertis Presenilin deficiency or lysosomal inhibition enhance Wnt signaling through relocalization of GSK3 to the late endosomal compartment Cell Rep. 2 5 2012 1316 1328 10.1016/j.celrep.2012.09.026
113. B.T. MacDonald, K. Tamai, and X. He Wnt/β-Catenin signaling: components, mechanisms, and diseases Dev. Cell. 17 2009 9 26 10.1016/j.devcel.2009.06.016
114. S. Angers, and R.T. Moon Proximal events in Wnt signal transduction Nat. Rev. Mol. Cell Biol. 10 2009 468 477 10.1038/nrm2717
115. H. Clevers, and R. Nusse Wnt/β-catening signaling and disease Cell 149 2012 1192 1205 10.1016/j.cell.2012.05.012
116. R.A. Boonen, P. van Tijn, and D. Zivkovic Wnt signaling in Alzheimer's disease: up or down, that is the question Ageing Res. Rev. 8 2009 71 82 10.1016/j.arr.2008.11.003
117. J. Bilic, Y.L. Huang, G. Davidson, T. Zimmermann, C.M. Cruciat, M. Bienz, and C. Niehrs Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation Science 316 2007 1619 1622
118. X. Zeng, H. Huang, K. Tamai, X. Zhang, Y. Harada, C. Yokota, K. Almeida, J. Wang, B. Doble, and J. Woodgett et al. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions Development 135 2008 367 375
119. V.F. Taelman, R. Dobrowolski, J.L. Plouhinec, L.C. Fuentealba, P.P. Vorwald, I. Gumper, D.D. Sabatini, and E.M. De Robertis Wnt signaling requires the sequestration of glycogen synthase kinase 3 inside multivesicular endosomes Cell 143 2010 1136 1148 10.1016/j.cell.2010.11.034
120. P. Brundin, R. Melki, and R. Kopito Prion-like transmission of protein aggregates in neurodegenerative diseases Nat. Rev. Mol. Cell Biol. 11 2010 301 307 10.1038/nrm2873
121. S. Maretto, M. Cordenonsi, S. Dupont, P. Braghetta, V. Broccoli, A.B. Hassan, D. Volpin, G.M. Bressan, and S. Piccolo Mapping Wnt/beta Catenin signaling during mouse development and in colorectaltumors Proc. Natl. Acad. Sci. USA 100 2003 3299 3304
122. A.M. Cataldo, S. Petanceska, C.M. Peterhoff, N.B. Terio, C.J. Epstein, A. Villar, E.J. Carlson, M. Staufenbiel, and R.A. Nixon App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome J. Neurosci. 23 2003 6788 6792
123. A. Salehi, J.D. Delcroix, P.V. Belichenko, K. Zhan, C. Wu, J.S. Valletta, R. Takimoto-Kimura, A.M. Kleschevnikov, K. Sambamurti, P.P. Chung, W. Xia, A. Villar, W.A. Campbell, L.S. Kulnane, R.A. Nixon, B.T. Lamb, C.J. Epstein, G.B. Stokin, L.S. Goldstein, and W.C. Mobley Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration Neuron 51 2006 29 42
124. Y. Jiang, K.A. Mullaney, C.M. Peterhoff, S. Che, S.D. Schmidt, A. Boyer-Boiteau, S.D. Ginsberg, A.M. Cataldo, P.M. Mathews, and R.A. Nixon Alzheimer's-related endosome dysfunction in down syndrome is A beta-independent but requires APP and is reversed by BACE-1 inhibition Proc. Natl. Acad. Sci. USA 107 2010 1630 1635 10.1073/pnas.0908953107
125. R.L. Neve, F.M. Boyce, D.L. McPhie, J. Greenan, and M.L. Oster-Granite Transgenic mice expressing APP-C100 in the brain Neurobiol. Aging 17 1996 191 203
126. J.H. Choi, J.D. Berger, M.J. Mazzella, J. Morales-Corraliza, A.M. Cataldo, R.A. Nixon, S.D. Ginsberg, E. Levy, and P.M. Mathews Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model J. Neurochem. 110 6 2009 1818 1827 10.1111/j.1471-4159.2009.06277.x
127. P.M. Mathews, Y. Jiang, S.D. Schmidt, O.M. Grbovic, M. Mercken, and R.A. Nixon Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments J. Biol. Chem. 277 2002 36415 36424
128. M. Arbel, I. Yacoby, and B. Solomon Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies Proc. Natl. Acad. Sci. USA 102 2005 7718 7723
129. K.W. Lee, J.Y. Im, J.S. Song, S.H. Lee, H.J. Lee, H.Y. Ha, J.Y. Koh, B.J. Gwag, S.D. Yang, S.G. Paik, and P.L. Han Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein Neurobiol. Dis. 22 2006 10 24
130. S.D. Ginsberg, M.J. Alldred, S.E. Counts, A.M. Cataldo, R.L. Neve, Y. Jiang, J. Wuu, M.V. Chao, E.J. Mufson, R.A. Nixon, and S. Che Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression Biol. Psychiatry 68 10 2010 885 893 10.1016/j.biopsych.2010.05.030
131. K. Bettens, N. Brouwers, S. Engelborghs, T. De Pooter, P.P. De Deyn, K. Sleegers, and C. Van Broeckhoven DNMBP is genetically associated with Alzheimer dementia in the Belgian population Neurobiol. Aging 30 12 2009 2000 2009 10.1016/J.Neurobiolaging.2008.02.003
132. A. Harel, F. Wu, M.P. Mattson, C.M. Morris, and P.J. Yao Evidence for CALM in directing VAMP2 trafficking Traffic 9 3 2008 417 429 10.1111/J.1600-0854.2007.00694.X
133. A.B. Wolf, R.J. Caselli, E.M. Reiman, and J. Valla APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease Neurobiol. Aging 34 4 2013 1007 1017 10.1016/j.neurobiolaging.2012.10.011
134. L. Bertram, and R.E. Tanzi Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat. Rev. Neurosci. 9 2008 768 778 10.1038/nrn2494
135. K. Horsburgh, M.O. McCarron, F. White, and J.A. Nicoll The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models Neurobiol. Aging 21 2 2000 245 255
136. D.H. Mauch, K. Nägler, S. Schumacher, C. Göritz, E. Müller, A. Otto, and F. Pfrieger CNS synaptogenesis promoted by glia-derived cholesterol Science 294 2001 1354 1357
137. S. Bellosta, B.P. Nathan, M. Orth, L.M. Dong, R.W. Mahley, and R.E. Pitas Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth J. Biol. Chem. 270 1995 27063 27071
138. D.M. Holtzman, R.E. Pitas, J. Kilbridge, B. Nathan, R.W. Mahley, G. Bu, and A.L. Schwartz Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous systemderived neuronal cell line Proc. Natl. Acad. Sci. USA 92 1995 9480 9484
139. B.P. Nathan, S. Bellosta, D.A. Sanan, K.H. Weisgraber, R.W. Mahley, and R.E. Pitas Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro Science 264 1994 850 852
140. B.P. Nathan, K.C. Chang, S. Bellosta, E. Brisch, N. Ge, R.W. Mahley, and
141. B.P. Nathan, Y. Jiang, G.K. Wong, F. Shen, G.J. Brewer, and R.G. Struble Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein Brain Res. 928 2002 96 105
142. Z. Qiu, B.T. Hyman, and G.W. Rebeck Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons J. Biol. Chem. 279 2004 34948 34956
143. S.B. Dumanis, J.A. Tesoriero, L.W. Babus, M.T. Nguyen, J.H. Trotter, M.J. Ladu, E.J. Weeber, R.S. Turner, B. Xu, G.W. Rebeck, and H.S. Hoe ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo J. Neurosci. 29 2009 15317 15322 10.1523/JNEUROSCI.4026-09.2009
144. Y. Ji, Y. Gong, W. Gan, T. Beach, D.M. Holtzman, and T. Wisniewski Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients Neuroscience 122 2003 305 315
145. J. Herz, and Y. Chen Reelin, lipoprotein receptors and synaptic plasticity Nat. Rev. Neurosci. 7 2006 850 859
146. R.C. Klein, B.E. Mace, S.D. Moore, and P.M. Sullivan Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2 Neuroscience 171 2010 1265 1272 10.1016/j.neuroscience.2010.10.027
147. K.M. Korwek, J.H. Trotter, M.J. Ladu, P.M. Sullivan, and E.J. Weeber ApoE isoform-dependent changes in hippocampal synaptic function Mol. Neurodegener. 4 2009 21 10.1186/1750-1326-4-21
148. G. Li, N. Bien-Ly, Y. Andrews-Zwilling, Q. Xu, A. Bernardo, K. Ring, B. Halabisky, C. Deng, R.W. Mahley, and Y. Huang GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice Cell Stem Cell 5 2009 634 645 10.1016/j.stem.2009.10.015
149. C.P. Yang, J.A. Gilley, G. Zhang, and S.G. Kernie ApoE is required for maintenance of the dentate gyrus neural progenitor pool Development 4362 2011 4351 4362 10.1242/dev.065540
150. K.R. Bales, Y. Du, D. Holtzman, B. Cordell, and S.M. Paul Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E Neurobiol. Aging 21 2000 427 432
151. F.M. Harris, I. Tesseur, W.J. Brecht, Q. Xu, K. Mullendorff, S. Chang, T. Wyss-Coray, R.W. Mahley, and Y. Huang Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease J. Biol. Chem. 279 2004 3862 3868
152. Y. Huang, X.Q. Liu, T. Wyss-Coray, W.J. Brecht, D.A. Sanan, and R.W. Mahley Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons Proc. Natl. Acad. Sci. USA 98 2001 8838 8843
153. F.M. Harris, W.J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J.D. Fish, E. Masliah, P.C. Hopkins, K. Scearce-Levie, K.H. Weisgraber, L. Mucke, R.W. Mahley, and Y. Huang Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice Proc. Natl. Acad. Sci. USA 100 2003 10966 10971
154. T. Nakamura, A. Watanabe, T. Fujino, T. Hosono, and M. Michikawa Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells Mol. Neurodegener. 4 2009 35 10.1186/1750-1326-4-35
155. I. Tesseur, J. Van Dorpe, K. Bruynseels, F. Bronfman, R. Sciot, A. Van Lommel, and F. Van Leuven Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord Am. J. Pathol. 157 2000 1495 1510
156. G.D. Schellenberg, and T.J. Montine The genetics and neuropathology of Alzheimer's disease Acta Neuropathol. 124 2012 305 323 10.1007/s00401-012-0996-2
157. L. Jones, D. Harold, and J. Williams Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease Biochim. Biophys. Acta 1801 2010 754 761 10.1016/j.bbalip.2010.04.005
158. T. Nuutinen, T. Suuronen, A. Kauppinen, and A. Salminen Clusterin: a forgotten player in Alzheimer's disease Brain Res. Rev. 61 2009 89 104 10.1016/j.brainresrev.2009.05.007
159. G. Ren, P. Vajjhala, J.S. Lee, B. Winsor, and A.L. Munn The BAR domain proteins: molding membranes in fission, fusion, and phagy Microbiol. Mol. Biol. Rev. 70 2006 37 120
160. E.J. Ungewickell, and L. Hinrichsen Endocytosis: clathrin-mediated membrane budding Curr. Opin. Cell Biol. 19 2007 417 425
161. S. Capsoni, G. Amato, D. Vignone, C. Criscuolo, A. Nykjaer, and A. Cattaneo Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation Biochem. Biophys. Res. Commun. 431 3 2013 579 585 10.1016/j.bbrc.2013.01.007
162. C. Gustafsen, S. Glerup, L.T. Pallesen, D. Olsen, O.M. Andersen, A. Nykjær, P. Madsen, and C.M. Petersen Sortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor protein J. Neurosci. 33 2013 64 71 10.1523/JNEUROSCI.2371-12.2013
163. A.S. Carlo, C. Gustafsen, G. Mastrobuoni, M.S. Nielsen, T. Burgert, D. Hartl, M. Rohe, A. Nykjaer, J. Herz, J. Heeren, S. Kempa, C.M. Petersen, and T.E. Willnow The pro-neurotrophin receptor sortilin is a major neuronal APOE receptor for catabolism of amyloid-peptide in the brain J. Neurosci. 33 2013 358 370 10.1523/JNEUROSCI.2425-12.2013
164. D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs J. Biol. Chem. 267 1 1992 546 554
165. J.D. Buxbaum, M. Oishi, H.I. Chen, R. Pinkas-Kramarski, E.A. Jaffe, S.E. Gandy, and P. Greengard Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor Proc. Natl. Acad. Sci. USA 89 21 1992 10075 10078
166. M.A. Smith, J.A. Joseph, and G. Perry Arson. Tracking the culprit in Alzheimer's disease Ann. N.Y. Acad. Sci. 924 2000 35 38
167. D. Goldgaber, H.W. Harris, T. Hla, T. Maciag, R.J. Donnelly, J.S. Jacobsen, M.P. Vitek, and D.C. Gajdusek Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells Proc. Natl. Acad. Sci. USA 86 19 1989 7606 7610
168. J.A. Josepha, G. Perry, B. Shukitt-Hale, N.A. Denisova, A. Antonio Martin, and M.A. Smith A diet at amyloid beta? Neurobiol. Aging 22 1 2001 161 163
169. J.D. Buxbaum, K.N. Liu, Y. Luo, J.L. Slack, K.L. Stocking, J.J. Peschon, R.S. Johnson, B.J. Castner, D.P. Cerretti, and R.A. Black Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor J. Biol. Chem. 273 43 1998 27765 27767